Nothing Special   »   [go: up one dir, main page]

Foitzik et al., 2000 - Google Patents

Control of murine hair follicle regression (catagen) by TGF‐β1 in vivo

Foitzik et al., 2000

View PDF @Full View
Document ID
4935168288848571656
Author
Foitzik K
Lindner G
Mueller‐Roever S
Maurer M
Botchkareva N
Botchkarev V
Handjiski B
Metz M
Hibino T
Soma T
Paolo Dotto G
Paus R
Publication year
Publication venue
The FASEB Journal

External Links

Snippet

The regression phase of the hair cycle (catagen) is an apoptosis‐driven process accompanied by terminal differentiation, proteolysis, and matrix remodeling. As an inhibitor of keratinocyte proliferation and inductor of keratinocyte apoptosis, transforming growth …
Continue reading at faseb.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetic or similar toilet preparations
    • A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
    • A61K8/30—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Similar Documents

Publication Publication Date Title
Foitzik et al. Control of murine hair follicle regression (catagen) by TGF‐β1 in vivo
Foitzik et al. The TGF-β2 isoform is both a required and sufficient inducer of murine hair follicle morphogenesis
Kimura-Ueki et al. Hair cycle resting phase is regulated by cyclic epithelial FGF18 signaling
Oda et al. Vitamin D and calcium regulation of epidermal wound healing
Ma et al. Cyclic alopecia'in Msx2 mutants: defects in hair cycling and hair shaft differentiation
McKay et al. Altered keratinocyte growth and differentiation in psoriasis
Grachtchouk et al. Basal cell carcinomas in mice arise from hair follicle stem cells and multiple epithelial progenitor populations
Reddy et al. Characterization of Wnt gene expression in developing and postnatal hair follicles and identification of Wnt5a as a target of Sonic hedgehog in hair follicle morphogenesis
Sasaki et al. Influence of prostaglandin F2α and its analogues on hair regrowth and follicular melanogenesis in a murine model
Liu et al. Keratin 15 promoter targets putative epithelial stem cells in the hair follicle bulge
Niemann et al. Expression of ΔNLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours
Lee et al. Targeting of CXXC5 by a competing peptide stimulates hair regrowth and wound-induced hair neogenesis
Weiner et al. Dedicated epithelial recipient cells determine pigmentation patterns
Semenova et al. Overexpression of mIGF-1 in keratinocytes improves wound healing and accelerates hair follicle formation and cycling in mice
Cai et al. Genetic interplays between Msx2 and Foxn1 are required for Notch1 expression and hair shaft differentiation
Yano et al. Thrombospondin-1 plays a critical role in the induction of hair follicle involution and vascular regression during the catagen phase
US6712617B2 (en) Methods of preventing UVB-induced skin damage
Wang et al. Type II epithelial keratin 6hf (K6hf) is expressed in the companion layer, matrix, and medulla in anagen-stage hair follicles
Ren et al. Lgr4 deletion delays the hair cycle and inhibits the activation of hair follicle stem cells
Sredni et al. Hair growth induction by the tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras‐dependent up‐regulation of KGF expression
Zhou et al. CD133-positive dermal papilla-derived Wnt ligands regulate postnatal hair growth
Jave-Suarez et al. Androgen regulation of the human hair follicle: the type I hair keratin hHa7 is a direct target gene in trichocytes
Ridanpää et al. Dynamic expression and nuclear accumulation of β-catenin during the development of hair follicle-derived structures
Hachiya et al. Stem cell factor–KIT signalling plays a pivotal role in regulating pigmentation in mammalian hair
Montuenga et al. Coordinate expression of transforming growth factor-β1 and adrenomedullin in rodent embryogenesis